Group Psychotherapy for People With HIV
This study has been completed.
Sponsor:
Collaborator:
Stanford University
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00186550
First received: September 13, 2005
Last updated: February 29, 2008
Last verified: February 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will examine the effectiveness of supportive-expressive group therapy plus education compared with an educational intervention in improving the quality of life and promoting health-enhancing behavior of men and women living with HIV or AIDS.
| Condition | Intervention | Phase |
|---|---|---|
|
HIV Depression Risk-Taking Pain |
Behavioral: Supportive Expressive Group Psychotherapy Behavioral: Education |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | An Evaluation of Group Psychotherapy for People With HIV |
Resource links provided by NLM:
Further study details as provided by National Institute of Mental Health (NIMH):
| Study Completion Date: | November 2000 |
The major goal of this project is to examine the effectiveness of supportive-expressive group therapy plus education in comparison to an educationally intervention in improving the quality of life and promoting health-enhancing behavior of men and women living with HIV/AIDS.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 1) a positive HIV diagnosis (either symptomatic or asymptomatic), 2) at least eighteen years of age, 3) English language skill (to complete questionnaires and participate, if assigned, to the group psychotherapy condition) and, 4) geographical proximity to groups in order to attend if assigned.
Exclusion Criteria:
- 1) severe psychiatric disorders (i.e. schizophrenia or other psychotic disorders)who would not be appropriate for participating in the group intervention, 2) active tuberculosis, 3) acute intoxication, 4) participation in an ongoing HIV/AIDS support group or 5) suicidal/homicidal ideation.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186550
Locations
| United States, California | |
| Stanford University | |
| Stanford, California, United States, 94305 | |
Sponsors and Collaborators
Stanford University
Investigators
| Principal Investigator: | David Spiegel, M.D. | Stanford University |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00186550 History of Changes |
| Other Study ID Numbers: | MH54930 |
| Study First Received: | September 13, 2005 |
| Last Updated: | February 29, 2008 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Depression Depressive Disorder Behavioral Symptoms Mood Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013